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1. Introduction 
Diabetes is one of the most prevailing metabolic disorders worldwide.  The number of 
individuals suffering from diabetes is increasing significantly. There are two main types of 
diabetes; Type 1 Diabetes mellitus (T1D) and Type 2 Diabetes mellitus (T2D).  T1D results 
from autoimmune destruction of insulin-producing pancreatic beta-cells.  This results in a 
complete loss of insulin, a hormone that is essential for loading any excess circulating 
glucose into target organs.  Individuals with T1D therefore need daily injections of insulin 
so as to regulate their circulating blood glucose concentrations and survive with the disease.  
Although such lifelong insulin therapy supports glucose metabolism, patients often develop 
complications related to renal function, endothelial damage and retinopathy.  T1D usually 
develops in children or young adults.   T2D on the other hand results from insulin 
resistance, a condition in which insulin is not properly recognized by receptors on cell 
surface.  It is sometimes combined with an absolute insulin deficiency as eventually these 
patients loose their β cells and are then classified as type 2 diabetic individuals requiring 
insulin. It usually occurs in people over 40 years of age, but is also being observed at 
younger age.  A cure for diabetes came in with the demonstration to support insulin action 
and regain the patient’s quality of life by transplantation of cadaveric insulin-producing 
cells (Tzakis et al., 1990).  Such a therapy, which in practice includes whole pancreas 
transplantation or transplantation of the endocrine portion; the islet of Langerhans, has been 
carried out in several patients suffering from Diabetes.  In year 2000, the Edmonton group 
successfully demonstrated transplantation of cadaveric islets using a steroid-free 
immunosuppressive regimen, which was a major advance in the field.  The Edmonton 
Protocol involves isolating islets from a cadaveric donor pancreas using enzymatic 
digestion.  Islets from one to as many as three donors were transplanted in to each recipient.  
Cadaveric islets are infused into the patient's portal vein, and are then kept from being 
destroyed by the recipient's immune system through the use of two immunosuppressants, 
sirolimus and tacrolimus (Shapiro et al., 2000).  Several hundred people have received islet 
transplants since 2000.  By a year after transplantation, about 50 - 68% of patients were 
observed off insulin, but by five years after the procedure, less than 10% of total patients 
were seen to be free of daily insulin injections.  One of the major factors in success of these 
www.intechopen.com
 
Stem Cells in Clinic and Research 534 
transplants has been the number of transplants / islet cell grafts received by these 
individuals.  For such a therapy to be available for several millions of people suffering from 
T1D it is necessary to identify other human cell sources that can be used for replacement 
therapy in diabetes.  
Several possible cell sources have been considered for obtaining insulin-producing cells. 
Our previous studies demonstrate that lineage committed stem cells such as pancreatic islet-
derived are better cell sources for treatment of diabetes.  We and others showed that 
progenitor cells generated from insulin-producing cells retain the active chromatin 
conformation of pancreatic or islet-specific lineage and hence can be differentiated into 
insulin-producing cells with better efficiency (Gershengorn et al., 2005; Gershengorn et al., 
2004; Joglekar and Hardikar; Joglekar et al., 2009a; Mutskov et al., 2007; Russ et al., 2008; 
Russ et al., 2009).  Apart from beta cells themselves, other pancreatic cell types (endocrine, 
acinar or ductal) are also demonstrated as potential candidate cell types (Baeyens et al., 
2005; Bonner-Weir et al., 2004; Lardon et al., 2004a; Lardon et al., 2004b).  Differentiation 
from human embryonic stem cells is also shown to generate insulin-producing cells 
(Blyszczuk et al., 2004). D’Amour et al illustrated this phenomenon (D'Amour et al., 2005; 
D'Amour et al., 2006) by recapitulating the normal sequence of embryonic developmental 
events that lead to beta-cell differentiation (Van Hoof et al., 2009).  It was demonstrated (Aoi 
et al., 2008; Nakagawa et al., 2008; Okita et al., 2007; Takahashi et al., 2007; Takahashi and 
Yamanaka, 2006) that forced expression of “reprogramming factors” (also known as the 
“Yamanaka factors”) allowed conversion of fibroblasts or somatic cells to an embryonic 
stem cell-like state.  These cells, referred to as induced pluripotent stem (iPS) cells are 
popular since they can be derived from adult somatic cells, including those from diabetic 
patients (Huangfu et al., 2008; Maehr et al., 2009), and could be potentially used for 
autologous transplantation in diabetes, if efficient differentiation is achieved.  Another study 
(Zhou et al., 2008; Zhou and Melton, 2008) also demonstrated that forced expression of 
pancreatic transcription factors (Pdx1, Ngn3 and MafA) induced insulin expression in 
exocrine pancreatic (acinar) cells.  We and others have also demonstrated (Bar et al., 2008; 
Joglekar et al., 2009a; Joglekar et al., 2009b; Russ et al., 2009) the role of several regulators in 
generation of islet-derived progenitors (via EMT) and their conversion to insulin-producing 
cells (via reverse-EMT or MET).  Mesenchymal stem cells obtained from non-endodermal 
tissues such as bone marrow, umbilical cord blood placenta, Wharton’s jelly, adipose tissue 
are also observed to differentiate to beta-like cells in vitro or in vivo (Chandra et al., 2009; 
Kadam et al.; Parekh et al., 2009; Phadnis et al.).  Although non-endodermal cells can be 
differentiated to insulin-producing cells in vitro, they are limited in their ability to efficiently 
transcribe insulin gene.    
Transdifferentiation, is a phenomenon that refers to differentiation of an already 
differentiated tissue to another differentiated cell type, possibly via de-differentiation and 
re-differentiation.  An example is the conversion of liver cells to pancreas (Ferber et al., 
2000).  More recently, we demonstrated evidence that human gallbladder epithelial cells 
contain pancreatic hormone-producing cells (Sahu et al., 2009a).  These observations are in 
line with similar observations made in mice (Coad et al., 2009).  Although the mechanisms 
that contribute to generation of hormone-producing cells in human gallbladder remain to be 
identified, these observations reveal that gallbladder epithelial cells can be a potentially 
important source of islet progenitors for cell replacement therapy in diabetes.  It is 
important to note that gallbladder and pancreas are next door neighbours during embryonic 
development (Figure 1).  In fact, the gallbladder develops from the ventral pancreatic bud.  
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Thus understanding the development of gallbladder-derived hormone-producing immature 
islet cells will help us in generating an alternate source of pancreatic stem cells for 
replacement therapy in diabetes.  In this chapter, we further emphasis on gallbladder and 
liver development and cells derived from these organs as potential candidates in cell 
replacement therapy for diabetes. 
2. Liver and gallbladder as cell sources to generate insulin producing cells 
Low yield and availability of transplantable islets from cadaveric pancreatic samples is a 
major concern in the field of cell replacement therapy for diabetes.  There is a wider search 
for cell sources with the potential to produce insulin at physiologically significant levels.  
Liver and gallbladder are next door neighbors to pancreas during embryonic development 
and share common expression territories for several transcription factors during embryonic 
development (Sahu et al., 2009b).  In this regard, the role of liver and especially gallbladder 
has come into picture recently.  During embryonic development, the development of 
pancreas begins with dorsal and ventral out-pouching of the gut tube.  Interestingly, the 
ventral pancreatic bud also gives rise to the gallbladder.  In this section we will discuss the 
developmental plans of liver and gallbladder in context of pancreas development.  
2.1 Liver function 
The liver is a large glandular organ that is well known due to its’ extensive regenerative 
capabilities as well as ability to trans-differentiate into pancreatic fate.  The liver is made up 
of hepatocytes with their basal surface facing the capillaries invading sinusoidal spaces.  The 
liver secretes bile through its apical surface into the canaliculi that join to form the biliary 
duct.  Biliary duct carries bile to gallbladder via hepatic duct.  The function of gallbladder is 
to concentrate and store bile, which is required for digestion of fats.  The adult rat liver 
consists of  60% hepatocytes while remaining mass consist of cholangiocytes, kuppfer cells, 
stellate cells and endothelial cells even those existing in sinusoidal spaces.  Although 
majority of liver parenchyma consists of hepatocytes, the interaction of hepatocytes with the 
non-parenchymal cells is important for normal liver function (Kmiec, 2001).  However, rats 
do not have a gallbladder while mice do.  Recently considerable amount of advances have 
been made in understanding the mechanisms that direct the development of bile duct. 
Although mechanisms involving gallbladder development have been less explored, studies 
from liver development have provided us with clues to understand the developmental 
biology of biliary duct and gallbladder.  
2.2 Embryonic development of the liver 
Liver development is a complex process involving fate decision, specification, proliferation 
and differentiation.  Development of liver begins with foregut development (involving 
Wnt/┚-catenin and FGF4), hepatic induction (by FGFs and BMPs), hepatic morphogenesis 
(involving transition from a simple cuboidal to pseudostratified columnar epithelium) and 
hepatic bud growth and maturation (influenced by signals from developing blood vesels).  
With the help of molecular genetic tools, tissue explant cultures and molecular biological 
techniques, liver development has been well understood in mice (Zaret, 1998; Zaret, 2000; 
Zorn and Wells, 2007).  The liver primordium appears as a diverticulum in the ventral 
region of the anterior intestinal portal at 9.0, 10.5, and 21days of gestation in mouse, rat, and 
human embryos, respectively (Du Bois, 1963; Shiojiri et al., 1991). This part of the ventral 
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foregut endoderm lies adjacent to heart and hence receives signals from cardiac mesoderm 
(Douarin, 1975; Fukuda-Taira, 1981; Fukuda, 1979).  As the development proceeds, liver 
primordium diverges into two portions in mouse and human embryos: the cranial and 
caudal lobe. The cranial diverticulum develops into the liver parenchyma and hepatic ducts 
while the caudal portion gives rise to gallbladder and the ventral pancreas (Shiojiri, 1997).  
At the early somite stage (14-20) or early stage of liver development i.e at embryonic day 
(e)9.5, the liver primordium is separated from septum transversum by basement membrane 
(Medlock and Haar, 1983).  As the liver bud grows this basement membrane is disrupted 
gradually and the pre-hepatic cells separate as layers from the foregut and migrate as cords 
into the surrounding septum transversum (Douarin, 1975; Medlock and Haar, 1983).  
Fibroblasts and stellate cells of liver are generated form septum transversum mesenchyme 
(STM).  Liver bud undergoes a period of accelerated growth between e10–15 to become the 
major hematopoietic organ, which is further colonized and vascularized by hematopoietic 
cells. 
The hepatoblasts are bi-potential cells that give rise to different types of cells including the 
biliary epithelial cells (BECs), intrahepatic bile ducts and hepatocytes depending on their 
distribution.  For example BECs are generated from hepatoblasts residing near portal vein 
while hepatocytes mainly originate from the hepatoblasts residing in the parenchyma.  BECs 
are also known as cholangiocytes and line the lumen of intrahepatic bile ducts (IHBD) 
(Lemaigre, 2003; Shiojiri, 1984).  The formation of biliary network, which connects to 
extrahepatic bile duct (EHBD) and maturation of hepatocytes is a gradual process that 
begins at e13 and continues after birth to achieve the characteristic tissue architecture. 
2.3 Endoderm formation 
The definitive endoderm emerges as a sheet of cells starting from the anterior end of the 
primitive streak during gastrulation.  The glandular and epithelial cells of lung, thyroid, 
pancreas, gastrointestinal and respiratory epithelium and of course the hepatocytes and the 
biliary epithelium originate from multipotent endoderm. Signaling by Nodal, a 
transforming growth factor beta (TGF┚) family growth factor initiates both endoderm and 
mesoderm formation in a concentration dependent manner.  Low nodal doses are seen to 
induce mesoderm while high dose induce endoderm (Shen, 2007; Zorn and Wells, 2007).  
Nodal  signaling stimulates core group of endoderm specific transcription factors including 
Sox17 (HMG domain DNA binding factor) and the fork head domain proteins Foxa1–3 
(hepatocyte nuclear factor or HNF 3┙/┚/┛) (Zorn and Wells, 2007), which in turn regulates 
the downstream genes committing cells to endodermal lineage. 
2.4 Endoderm patterning 
The cells that first emerge from the primitive streak give rise to the anterior part while those 
that arise later give rise to the posterior part (Lawson and Pedersen, 1987). Anterior 
endoderm development requires higher nodal signaling than the posterior endoderm.  It 
expresses Foxa2, as it is preferentially required for the formation of anterior definitive 
endoderm (Dufort et al., 1998; Zorn and Wells, 2007).  During the early somite stages of 
development, morphogenetic movement transforms the endoderm into an epithelial gut 
tube.  This epithelial gut tube is surrounded by mesoderm.  The mesoderm secretes several 
factors that regulate pattern formation along the epithelial gut tube along anterior- posterior 
(A-P) axis to form the foregut, midgut and hindgut regions.  These regions of endoderm are 
distinguishable by the expression of Hhex in foregut, Pancreatic and duodenal homeobox 1 
www.intechopen.com
 
Cell Sources for Treating Diabetes 537 
(Pdx1) in midgut and Cdx in posterior endoderm or hindgut (Grapin-Botton, 2005; Moore-
Scott et al., 2007).  The foregut endoderm contains common precursors for liver, gallbladder 
and pancreas. Initially the regional identity is “plastic” as recombination of the early foregut 
endoderm with the posterior endoderm results into intestinal fate instead of liver and 
pancreas development (Gualdi et al., 1996; Horb and Slack, 2001; Kumar et al., 2003; Wells 
and Melton, 2000). 
2.5 Repression of Wnt/β-catenin and FGF4 is required for foregut development 
Overlapping spatiotemporal gradients of Wnt, fibroblast growth factor (FGF), bone 
morphogenetic proteins (BMP) and retinoic acid secreted from the adjacent mesoderm, 
patterns the endoderm to express regionally specific genes (Chen et al., 2004; Dessimoz et 
al., 2006; Kumar et al., 2003; Martin et al., 2005; McLin et al., 2007; Roberts et al., 1995; 
Stafford et al., 2004; Tiso et al., 2002). For the development of foregut endoderm, inhibition 
of Wnt and FGF4 signaling by Wnt antagonist like Sfrp5 (secreted by the foregut endoderm) 
is essential (Dessimoz et al., 2006; McLin et al., 2007; Wells and Melton, 2000).  Obviously the 
posterior endoderm depends on the secretion of Wnt and FGF4 by the posterior mesoderm.  
Experimentally it has been demonstrated that blocking the canonical Wnt effector ┚-catenin 
in the posterior endoderm of Xenopus embryos activates Hex expression and results in 
ectopic liver bud formation in intestine (McLin et al., 2007). 
2.6 Hepatic competence 
The foregut endoderm is the only competent candidate in vivo to generate liver and its 
establishment is the first step towards hepatogenesis (Douarin, 1975; Fukuda-Taira, 1981). 
This intrinsic property to develop into liver is due to expression of transcription factors 
including Foxa2, Gata4-6 and Hhex (or Hex).  These transcription factors have important 
role in early organogenesis.  Foxa and Gata have been shown to bind to enhancer element of 
albumin gene and enhances chromatin accessibility thereby increasing the competency of 
such liver specific genes to be transcribed (Bossard and Zaret, 1998; Bossard and Zaret, 2000; 
Gualdi et al., 1996).  Evidently, deletion of Foxa1 and Foxa 2 prevents induction of liver 
development in early foregut. 
2.7 Hepatic induction by cardiac mesoderm and STM 
At an early somite stage of 4-7, FGF signals from the cardiac mesoderm of developing heart 
and BMPs from the STM induces hepatic fate in the ventral foregut endoderm (Douarin, 
1975; Fukuda-Taira, 1981; Gualdi et al., 1996; Jung et al., 1999; Rossi et al., 2001).  This has 
been illustrated in mouse models where the mouse foregut explants isolated at 2-4 somite 
stage when cultured in the presence of cardiac mesoderm start expressing albumin after 1-2 
days.  However removal of cardiac mesoderm or blocking FGF signals inhibited liver 
induction (Calmont et al., 2006; Gualdi et al., 1996; Rossi et al., 2001).  It has also been 
illustrated that exogenous FGF1 and FGF2 can replace cardiac mesoderm and induce 
albumin expression in foregut endoderm explants.  However BMP signaling may act by 
maintaining Gata4/6 expression and is not sufficient for hepatic induction in the explants 
(Rossi et al., 2001).  Analysis of downstream signal transduction pathway of FGF signaling 
suggests that P13 kinase pathway promotes hepatic growth while MAP kinase pathway 
regulates hepatic gene expression (Calmont et al., 2006).  Although the target genes of FGF 
and BMP signal have not been revealed due to early embryonic lethality, it is predicted that 
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they act cooperatively to regulate liver development.  Additionally, wnt2 and wnt2b are also 
expressed in the mouse lateral plate mesoderm at the time of hepatic induction but their role 
is yet to be determined.  Mouse explant studies have suggested that high, low and medium 
concentrations of FGFs are critical for segregation of different organs lung, liver and 
gallbladder respectively from a common progenitor cell.  It is not clear whether it is the 
proximity or the duration that the endoderm is in contact with the cardiac mesoderm that 
controls FGF doses.  Hhex, a homeobox protein regulates this process. It is responsible for 
the proliferation of foregut cells and the movement of epithelium in relation to the FGF-
secreting cardiac mesoderm during development (Bort et al., 2004). 
2.8 Endothelial cells signals in hepatogenesis 
At around e9.5 endothelial cells intersperse and form simple continuous vessels into the 
future parenchymal cells as it expands into septum transversum mesenchyme. As 
development proceeds, the morphology of the endothelial cells changes, becoming 
fenestrated and forming endothelial sheets that line the hepatic sinusoids (Bankston and 
Pino, 1980; Enzan et al., 1997).  The role of endothelial cells in hepatogenesis was illustrated 
by utilizing Flk-1-/-   mouse which lack mature endothelial cells or blood vessels (Shalaby et 
al., 1997; Shalaby et al., 1995).  In control mice, at an early stage, when liver starts 
developing, the endothelial cells are found between the hepatic bud and the septum 
transversum however Flk-1-/-   mice lack endothelial cells as expected. Comparison of control 
and Flk-1-/- embryos liver revealed that although hepatic specification occurred 
hepatogenesis failed and there were no signs of expansion or morphogenetic movement into 
the septum transversum. Flk expression is restricted to endothelial cells and not in STM and 
endoderm. Hence it was confirmed that endothelial cell signaling is a crucial aspect for 
normal hepatogenesis. 
2.9 Transcription factors and their roles in controlling hepatogenesis 
During embryonic development, hepatogenesis is defined by the precise timing and the 
location of tissue interactions and the signaling molecules involved therein. However the 
intracellular response to these signaling events explains the mechanisms through which the 
cells of endoderm actually adopt a hepatic fate. Large changes in gene expression patters 
accompany the differentiation of ventral endoderm towards hepatic phenotype. It is thus 
quite obvious that a lot of transcription factors are involved as gene regulation is tightly 
regulated by transcription factors (Cereghini, 1996; Duncan, 2000). Molecular biology and 
molecular genetics have been helpful in identifying a number of transcription factors that 
are crucial candidates to regulate various aspects of hepatogenesis. 
2.9.1 Transcription factors controlling hepatic competency  
Competency is described as the innate ability of a cell type to follow a developmental fate 
given appropriate inductive signals (Gilbert and MA., 2000; Waddington, 1940 ). The work 
of Gauldi et al suggests that both ventral and dorsal endoderm have the potential to express 
albumin gene (Gualdi et al., 1996).  However the laboratory of Ken Zaret have suggested a 
mechanism whereby Hnf3 (FoxA) and Gata4 could modulate competency intracellularly 
(Bossard and Zaret, 1998; Chaya et al., 2001; Cirillo et al., 2002; Gualdi et al., 1996; Shim et 
al., 1998). Extracts from e9.5 liver buds when used for in vivo foot printing analysis of 
Albumin enhancer revealed that several binding sites including Hnf3, Gata and Nf-1 sites 
were occupied.  However uncommitted cells from endoderm showed occupancy at Hnf3 
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and Gata sites only.  In addition, in vitro chromatin reconstitution assays elucidated that the 
binding of either Hnf3 or Gata4 resulted in the opening of compacted chromatin (Cirillo et 
al., 2002).  Thus Hnf3 and Gata were found responsible for remodeling of chromatin 
structure and hence were able to generate available receptive sites on them for the 
occupancy of transcriptional activators.  Supporting examples of this model is from the 
finding that Hnf3 can relieve the transcriptional repression of α-fetoprotein gene in 
transcription assays in vitro (Crowe et al., 1999).  A similar situation exists for the Gata factor 
as Gata 4 has been shown to bind the Albumin enhancer.  The expressions of these 
transcriptional activators are in turn controlled by inductive events. 
2.9.2 Role of Hex and Prox in early stages of liver development 
Hex (or Prh) encodes for divergent homeobox transcription factor known as 
hematopoietically-expressed homeobox protein. At an early head fold stage (pre-somite, 
e8.0), prior to the initiation of hepatogenesis, expression analysis of the Hex mRNA revealed 
that it is highly expressed throughout the ventral endoderm.  Expression within the ventral 
endoderm is restricted to two discrete areas that are future sites for liver and thyroid 
development by e8.5 or 10 somite stage (e8.5) (Keng et al., 1998; Thomas et al., 1998). Hence 
the early expression of Hex mRNA in ventral endoderm defines Hex as one of the earliest 
markers of liver development.  Role of Hex was discerned using Hex -/- embryos at e9.5 to 
10.5.  These embryos show thickening of the ventral foregut endoderm but the expansion 
and morphogenetic outgrowth of liver was undetectable in contrast to the control embryos.  
In situ hybridization studies on Hex -/- embryos revealed the absence of α-fetoprotein 
mRNA expression at e9.5 and e10.5.  In another study using RT-PCR, absence of albumin 
was reported in these mutants (Keng et al., 2000; Martinez Barbera et al., 2000).  Knockout 
studies have also revealed the role of Prox 1 in early stages of liver development.  Analysis 
of Prox1-/- embryo found that the liver of these mutant embryos were smaller than the wild 
types and although these mutants formed distinct liver lobes the hepatic parenchymal cells  
 
 
Fig. 1. The human liver, gallbladder and pancreas are next door neighbors during 
embryonic development.  The gallbladder actually develops from the ventral pancreatic bud 
and is in close proximity to the developing pancreas until the ventral pancreas rotates to 
fuse with the dorsal pancreatic bud.  We therefore believe that this close proximity and 
overlapping expression pattern of pancreatic transcription factors in the domain of 
developing gallbladder induces expression of endocrine pancreatic hormones in the 
gallbladder. 
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were restricted to central rudiment (Sosa-Pineda et al., 2000).  These mutant embryos 
showed reduced number of hepatoblasts than control embryos.  These two characteristic of 
the mutant phenotype explains why these embryos failed to inhibit the mesenchymal 
portion of the liver.  At e10 Prox1-/- hepatoblasts mice failed to exhibit the delamination of 
hepatic chords into the septum transversum in contrast to control hepatoblasts which 
normally migrate as chords into the septum transversum. Although these mutants failed to 
expand and migrate, they were found positive for albumin and α-fetoprotein implying their 
specification toward hepatic fate (Sosa-Pineda et al., 2000).  In short, Prox 1 is dispensable 
for hepatic specification but it is required for morphogenic expansion of the liver 
primordium.  
2.9.3 Transcription factors in regulation of hepatocyte differentiation 
During 1980s enormous amount of work from several laboratories allowed the identification 
of the transcription factors that predominantly regulates the liver specific genes (Lai and 
Darnell, 1991; Sladek and Darnell, 1992). These transcription factors included Hnf1α and β , 
the c/EBP family, Hnf3α, β, and γ, Hnf4α, and more recently Hnf6 (Lai and Darnell, 1991; 
Lemaigre et al., 1996; Samadani and Costa, 1996; Sladek and Darnell, 1992). Knockout 
models for these factors have helped in studying the role of these factors in hepatic 
differentiation.  It was found that loss of a single factor generally has negligible effect.  For 
example disruption of either Hnf3α, Hnf3β or Hnf3γ in the liver does not affect hepatocyte 
differentiation, although moderate changes in expression of a subsets of hepatocyte genes 
have been described (Kaestner et al., 1998; Shih et al., 1999; Sund et al., 2000).  Functional 
redundancy could be the reason for this insignificant effect of disruption of single gene but 
its note worthy that disruption of Hnf3β  inhibits β-cell differentiation in pancreas although 
they express Hnf3α (Kaestner et al., 1998; Sund et al., 2000).  Noticeably disruption of some 
genes has serious effects in liver development.  For example the early liver development in 
c/EBPα−/−  embryos is normal although the neonates die from hypoglycemia due to failure of 
liver to accumulate glycogen.  In these mice, expression of glycogen synthase is disrupted 
and the bile canaliculi form abnormally (Wang et al., 1995). In addition hepatocyte 
proliferation was increased in the newborns c/EBPα−/−  liver.  This was supported by the fact 
that c/EBPα  inhibits cell proliferation by regulating S-phase-specific E2F–p107 complexes 
and by stabilisizing the cyclin dependent kinase inhibitor p21 (Harris et al., 2001; Timchenko 
et al., 1997; Timchenko et al., 1999). Hnf1α  mutants do not show significant effect on liver 
development, however mice lacking Hnf1α suffer from various different abnormalities 
depending on the targeted allele.  In one case, mice suffer from hepatic dysfunction, 
Phenylketonuria and renal Faconi’s syndrome, while a different gene targeting strategy 
generated mice that suffered from non-insulin-dependent diabetes mellitus (NIDDM) and 
Laron dwarfism.  Loss of function of phenylalanine hydroxylase (Pah) gene due to the 
inability of Hnf1α to facilitate modification of chromatin around the Pah promoter results 
Phenylketonuria (Pontoglio et al., 1996; Pontoglio et al., 1997). Hnf4α  mRNA was first 
detected in the primitive endoderm of the blastocyst at the time of implantation. 
Hnf4α expression was first detected in the liver bud at around 10 somite stage. Hnf4α 
expression was restricted to the ventral extraembryonic visceral endoderm which forms the 
endodermal portion of the yolk sac just before this developmental stage. Hnf4α  acts on the 
important effector in the hepatocyte development. Hnf4α positively regulates Hnf1α 
expression as evident by the presence of Hnf4α binding sites on the transcriptional 
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regulatory element of Hnf1α. Hnf4α slightly precedes the expression of Hnf1α in number of 
tissues in which both factors are expressed. Although hepatoblasts during liver 
development are relatively immature, they still initiate expression of genes that define 
mature hepatocyte phenotype. When the mRNA levels of such genes were compared 
between control and Hnf4α−/− livers it was found that the expression of 14 genes that have 
important roles in hepatocyte function were either undetectable in some cases or down-
regulated in others in the absence of Hnf4α (Li et al., 2000). These results have also been 
consistent with the adult hepatocytes that lack Hnf4α (Hayhurst et al., 2001). All of these 
studies strongly support the notion that Hnf4α is a central regulator of hepatocyte 
differentiation.  
2.10 Transcription factors in gallbladder and intrahepatic bile duct development 
The gallbladder and liver share several common transcription factors during embryonic 
development.  In developing mouse liver, HNF6 is expressed in hepatocytes and in the 
epithelial cells of both the intrahepatic and extrahepatic bile ducts (Landry et al., 1997; Rausa et 
al., 1997). Recent studies illustrate that Hnf6-/- mouse embryos fail to develop a gallbladder 
and exhibit severe abnormalities in both extrahepatic and intrahepatic bile ducts (IHBD), 
which is associated with diminished expression of the Hnf1β  transcription factor (Clotman et 
al., 2002; Jacquemin et al., 2000).  Thus Hnf6 is essential for regulating the expression of 
Hnf1β, which in turn plays important role in intrahepatic bile duct and gall bladder 
development. Foxf1 is another transcription factor involved in gallbladder development.  It is 
expressed in the embryonic gut mesoderm and septum transversum.  It participates in the 
mesenchymal-epithelial cell inductive signaling of the internal organs. Foxf1+/- mice show 
several developmental abnormalities in gallbladder, esophagus, lung and trachea which 
supports this hypothesis (Kalinichenko et al., 2001; Kalinichenko et al., 2002; Mahlapuu et al., 
2001). Foxf1+/- gallbladder fails to express vascular cell adhesion molecule-1, α5 integrin, and 
platelet-derived growth factor receptor α and hepatocyte growth factor genes required for 
mesenchymal epithelial cell induction (Kalinichenko et al., 2002).  Foxf1+/- gallbladder shows 
malformations in external smooth muscle cell layer, reduction in mesenchymal cell number 
and in some cases, lack of a discernible biliary epithelial cell layer (Kalinichenko et al., 2002).  
There is little information available regarding the development of gallbladder.  Present 
knowledge is gained based on a few knockout studies that are summarized in the table below.  
It suggests a need to generate more similar information for better understanding of molecular 
pathways regulating the development of hormone-producing cells in gallbladder. 
 
No. Gene name Phenotype Ref 
1 forkhead box F1a 
(Foxf1) 
Heterozygotes of Foxf1 knockout 
animals (haplosufficient) have 
severely abnormal and small gall 
bladder and they lack epithelial cell 
layer 
Kalinichenko et 
al, Journal of 
Biological 
Chemistry, 2002, 
227:12369-12374 
2 One cut domain 
family member 1 
(Onecut1/ Hnf6) 
Hnf6 null mice lack gall bladder.  
Extrahepatic as well as intrahepatic 
bile ducts are abnormally developed 
Clotman et al, 
Development, 
2002, 129:1819-
1828 
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No. Gene name Phenotype Ref 
3 Hairy and enhancer 
of split 1 (Hes 1) 
Hes1 knockout animals do not 
develop gall bladder and have 
severely reduced extrahepatic bile 
ducts.  Such mutant bile ducts 
express Ngn3 and ectopically 
differentiate into pancreatic exocrine 
and endocrine tissue 
Sumazaki et al, 
Nature Genetics, 
2004, 36:83-87 
4 Hematopoietically 
expressed 
homeobox (Hhex) 
Conditional deletion of Hhex in 
hepatic diverticulum is embryonic 
lethal and results in small, cystic 
liver.  Gall bladder and extrahepatic 
bile duct are absent.   Conditional 
deletion of Hhex in embryonic liver is 
not lethal, however it precipitates into 
irregular development leading to 
polycystic liver disease in adulthood  
Hunter et al, 
Developmental 
Biology, 2007, 
308:355-367 
5 Leucine-rich repeat-
containing G 
protein-coupled 
receptor 4 (LGR4) 
LGR4 hypomorphic embryos develop 
normal gall bladder bud at e10.25, 
however it does  not elongate in later 
stages of development.  Adult mouse 
completely lacks gall bladder and 
cystic duct.  Liver and pancreas are 
unaffected.  
Yamashita et al, 
Developmental 
Dynamics, 2009, 
238:993-1000 
6 Hepatocyte nuclear 
factor beta Hnf1β 
 
 
 
HNF1b deletion results into severe 
jaundice caused by abnormalities in 
intrahepatic bile ducts and 
gallbladder. It also leads to reduced 
expression of Organic Anion 
Transporting Polypeptide 1 or Oatp1, 
bile acid transporter and fatty acid 
dehydrogenase or Very long-chain 
acyl-CoA dehydrogenase VLCAD. 
Coffinier C et al, 
Development 
2002; 129:1829–
1838. 
7 Hlx -/- Expression of Hlx is seen in visceral 
mesenchyme of the developing liver, 
gallbladder, and gut. Hlx -/- embryos 
exhibit normal formation of the liver 
diverticulum and differentiation of 
hepatocytes , but the cells fail to 
proliferate and therefore develop  
into under-sized liver (3% of normal 
size). 
Hentsch B et al,  
Genes Dev 
1996;10:70-79. 
 
 
Table 1. Phenotypes of the knockout mouse models for the genes involved in gallbladder 
development. 
www.intechopen.com
 
Cell Sources for Treating Diabetes 543 
3. Concluding remarks 
Liver, gallbladder and pancreas originate from nearby regions of endoderm and develop 
in close association with each other (Figure 1).  It is quite evident and exciting to note that 
these organs share several transcription factors (Sahu et al., 2009b).  The liver shares 
expression of genes such as Glut2 and glucokinase and as discussed earlier has the same 
embryological origin as ventral pancreas.  It is hence encouraging that the cells derived 
from organs outside pancreas can be useful in generating insulin producing cells for cell 
replacement therapy in diabetes.  It has been demonstrated that ectopic expression of 
Pdx1 in liver ameliorates type 1 diabetes through conversion of hepatocytes in to insulin-
producing cells (Ferber et al., 2000).  Precisely diabetic CAD-NOD mice treated with Ad-
CMV-PDX-1 became normoglycemic and maintained a stable body weight.  Ectopic PDX-
1 expression induced pancreatic gene expression and insulin production in the mice livers 
(Ferber et al., 2000).  Retrovirally immortalized human fetal liver progenitor cells when 
transduced using lentiviral vector containing PDX1 underwent successful differentiation 
into insulin-expressing cells. These cells showed responsiveness to glucose, exhibit a ┚-
cell-like phenotype and are able to restore euglycemia upon transplantation in diabetic 
mice (Zalzman et al., 2005; Zalzman et al., 2003).  Forced expression of Pdx1 is now 
known to induce conversion of human fetal liver cells to insulin-producing cells.  These 
modified cells express multiple beta cell specific genes. However, they also activated 
genes expressed in exocrine pancreas and continued expressing hepatic genes as well.  
Similarly expression of another beta cell transcription factor; NeuroD, in mouse liver cells 
in vivo resulted in reversal of hyperglycemia (Kojima et al., 2003).  This phenomenon was 
promoted by the presence of betacellulin.  Manipulation of the culture conditions (by 
using activin A in serum free medium for differentiation) of the Pdx1-expressing human 
fetal liver cells was shown to further promote the differentiation of these cells towards the 
beta-cell phenotype, as judged by insulin content and gene expression (Zalzman et al., 
2005; Zalzman et al., 2003).  All of the above studies involve genetic manipulation of stem 
/ propgenitor cells.  Such in vitro manipulated cells cannot be used for treatment of 
diabetes in humans.  It is therefore necessary to identify a source of human insulin-
producing or islet progenitor cells that can efficiently transcribe, translate and secrete 
insulin. 
At present, human cadaveric pancreas is the ultimate source of such insulin-producing 
cells for replacement therapy in diabetes.  Although this therapy has potential to cure 
diabetes, there is a significant scarcity in number of cadaveric pancreas available for 
transplantation (~30 “good” pancreas/year in Australia).  In contrast to this, there are 
several hundreds of gallbladders available every year from just one surgical team in 
Melbourne, Australia.  In other speciality GI centres, this number is over a thousand every 
year.  The level of insulin transcript seen in gallbladder is 1000-fold less (Ct value 22-26) 
than that observed in pancreas (Ct value 12-16).  This level of insulin gene expression is 
already significantly higher than any of the differentiated stem cells reported until now.  
Gallbladder cells naturally exhibit insulin expression higher that the differentiated stem 
cells and hence there is scope for enhancement of expression levels of insulin in 
gallbladder derived cells upon differentiation/maturation. Further research in 
understanding the maturation / expansion and differentiation of gallbladder-derived islet 
progenitor cells will help in providing alternative source for cell replacement therapy in 
diabetes.  
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